ReviewFrontiers in immunology2026
Metabolic reprogramming networks in the gastric cancer tumor microenvironment: an integrated axis of nutrient competition, metabolic crosstalk, and immunosuppression.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastric cancer ranks among the most prevalent malignant tumors globally, with its immunotherapeutic efficacy constrained by the intricate tumor microenvironment (TME). This review provides a systematic elucidation of the dynamic interaction axis of "nutrient competition-metabolic crosstalk-immunosuppression" within the TME of gastric cancer, approached from a network perspective. Initially, the hypoxic, acidic, and nutrient-deficient conditions of the TME establish a metabolic pressure foundation, compelling cancer and immune cells to engage in intense competition for essential nutrients, thereby inducing a state of metabolic deprivation in effector T cells. Subsequently, this competitive dynamic results in the accumulation of immunosuppressive metabolites, including lactic acid, adenosine, kynurenine, and prostaglandin E2. These metabolites, rather than being mere waste products, form a complex metabolic crosstalk network that actively suppresses effective immune function and reshapes the immunosuppressive niche through mechanisms such as receptor signaling and epigenetic modification. Ultimately, this multi-layered metabolic reprogramming network collectively facilitates immune evasion and resistance to immunotherapy in gastric cancer. A comprehensive analysis of the network is anticipated to furnish a vital theoretical foundation for the development of novel therapeutic strategies. These strategies may include targeting pivotal metabolic nodes, alleviating immunosuppression, and integrating immune checkpoint blockade, all of which are expected to enhance the clinical prognosis of patients with gastric cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.